,A review on generation of real-world evidence

被引:0
|
作者
Shunmugavelu, Meenakshi Sundaram [1 ]
Panda, Jayanta Ku [2 ]
Sehgal, Ashish [3 ]
Makkar, Brij Mohan [4 ]
机构
[1] Trichy Diabet Specialty Ctr, Trichy 620018, Tamil Nadu, India
[2] SCB Med Coll Odisha, Cuttack, Odisha, India
[3] Diabet Med, New Delhi, India
[4] Cleveland Clin, Adv Certificate Courses Diabet, New Delhi, India
来源
CLINICAL DIABETOLOGY | 2021年 / 10卷 / 05期
关键词
real-world evidence; healthcare policies; real-world data; pragmatic trials; policy making; RANDOMIZED CONTROLLED-TRIALS; INSULIN DEGLUDEC; BASAL INSULIN; MULTICENTER; LIMITATIONS; POPULATION; THERAPY; SAFETY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Real-world evidence can generate credible evidence to inform treatment decisions. Real-world evidence is in developmental stage and is fast evolving yet there are many unexplained attributes of real-world evidence. Real-world evidence informs benefit-risk decisions and is increasingly being used to support regulatory decision making. Potential benefits of real-world data include determination of extended outcomes including long-term outcomes, opportunities to partner with patients in innovative ways, and reduction in time and cost to generate dependable evidence. Limitations of real-world evidence include uncertainty in the quality of datasets and lack methodologic rigor in real-world studies. Use of real-world evidence for healthcare practices and policies is limited. Ensuring completeness, homogeneity, and linkage of datasets can enhance utility for epidemiological investigations and improvement in health outcomes. Research should be strengthened for real-world studies and technical standards should be reinforced. Collaborations of stakeholders is key to formulation and adoption of guidance for real-world evidence. Real-world data cannot be a substitute to randomized clinical studies but can possibly augment the generated evidence.
引用
收藏
页码:412 / 419
页数:8
相关论文
共 50 条
  • [1] BARRIERS AND SOLUTIONS FOR REAL-WORLD CHART REVIEW EVIDENCE GENERATION
    Stein, D.
    Ross, L.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A342 - A342
  • [2] Data Science Methods for Real-World Evidence Generation in Real-World Data
    Liu, Fang
    [J]. ANNUAL REVIEW OF BIOMEDICAL DATA SCIENCE, 2024, 7 : 201 - 224
  • [3] A DIAGNOSTIC FRAMEWORK TO EVALUATE REAL-WORLD DATA SOURCES FOR REAL-WORLD EVIDENCE GENERATION
    Denysyk, L.
    Doyle, J.
    Sood, R.
    [J]. VALUE IN HEALTH, 2018, 21 : S89 - S89
  • [4] Real-World Evidence: A Review of Real-World Data Sources Used in Orthopaedic Research
    Hak, David J.
    Mackowiak, John I.
    Irwin, Debra E.
    Aldridge, Molly L.
    Mack, Christina D.
    [J]. JOURNAL OF ORTHOPAEDIC TRAUMA, 2021, 35 : S6 - S12
  • [5] Real-world study: from real-world data to real-world evidence
    Wen, Yi
    [J]. TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1
  • [6] REAL-WORLD EVIDENCE GENERATION IN JAPAN - USES AND CHALLENGES
    Graham, S.
    Laurent, T.
    Simeone, J.
    Kuwatsuru, R.
    Hirano, T.
    Phillips, R.
    Isomura, T.
    [J]. VALUE IN HEALTH, 2021, 24 : S194 - S194
  • [7] Real-world Data for Clinical Evidence Generation in Oncology
    Khozin, Sean
    Blumenthal, Gideon M.
    Pazdur, Richard
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (11)
  • [8] Translating real-world evidence/real-world data
    Ravenstijn, Paulien
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (05):
  • [9] Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidence
    Coyne, Daniel W.
    Sprague, Stuart M.
    Vervloet, Marc
    Ramos, Rosa
    Kalantar-Zadeh, Kamyar
    [J]. JOURNAL OF NEPHROLOGY, 2022, 35 (03) : 875 - 888
  • [10] Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidence
    Daniel W. Coyne
    Stuart M. Sprague
    Marc Vervloet
    Rosa Ramos
    Kamyar Kalantar-Zadeh
    [J]. Journal of Nephrology, 2022, 35 : 875 - 888